The therapeutic compositions can be and formulated to reduce the extent of {HEAD ~ a Plasmodium infection} in {TAIL ~ the recipient subject}, or to reduce the likelihood of the onset or establishment of a Plasmodium infection if administered prior to the parasite contacting the subject 
in
The therapeutic compositions can be and formulated to reduce the extent of { HEAD ~ a Plasmodium infection } in { TAIL ~ the recipient subject } , or to reduce the likelihood of the onset or establishment of a Plasmodium infection if administered prior to the parasite contacting the subject
OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH HEAD HEAD HEAD HEAD HEAD HEAD HEAD REL TAIL TAIL TAIL TAIL TAIL TAIL TAIL OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH